Release Date: March 18, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide more details on the changes in Germany's cannabis market and your strategy there? A: Raj Grover, CEO: We remain committed to entering the German medical cannabis market. The recent election in Germany brought the CDU party to power, which has raised concerns about telemedicine platforms. This has impacted our plans with Purecan, leading us to reconsider the structure of our partnership. We are exploring other opportunities and remain focused on entering the market, regardless of the partner. We are also prepared for potential recreational market opportunities in Germany.
Q: What are the dynamics in Canada regarding consumer preferences and market share? A: Raj Grover, CEO: Our long-term goal is to achieve a 15% market share in Canada. We have seen a 5% increase in same-store sales this quarter, and since launching our discount club model in 2021, we've grown same-store sales by 142%. Despite the resurgence of the illicit market, we believe cannabis is recession-resistant, and we are not significantly impacted by inflation or tariffs.
Q: What is the timeline for entering the German market, and are you considering other partners besides Purecan? A: Raj Grover, CEO: We are actively exploring partnerships beyond Purecan and are in discussions with other groups. We aim to enter the German market within a couple of months, ensuring we select the right partner to leverage our strong network and relationships in Canada.
Q: How do tariffs impact your business, particularly regarding accessories sourced from China? A: Raj Grover, CEO: Tariffs have minimal impact on our business. Only 1% of our business involves cross-border transactions, and we procure accessories through internal brokers, insulating us from tariff effects. Our CBD business is domestically sourced, and we are well-protected from tariff impacts.
Q: What factors contributed to the acceleration of retail sales growth in Canada, and how has the HST break impacted cannabis sales? A: Raj Grover, CEO: The acceleration in sales growth is likely due to the leveling off of negative growth trends and the expansion of legal stores. While the HST break may have contributed, we believe the market's natural growth and cannabis's recession-resistant nature are more significant factors. We continue to see positive momentum in our current quarter.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.